Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal

Secretion of the anterior pituitary hormone prolactin can be significantly increased by antipsychotic drugs, leading to a range of adverse effects in patients with schizophrenia. However, there is evidence from a variety of studies that prolactin may also be related to symptom profile and treatment...

Full description

Saved in:
Bibliographic Details
Published in:Schizophrenia Research and Treatment 2014-01, Vol.2014 (2014), p.3-14
Main Author: Rajkumar, Ravi Philip
Format: Article
Language:English
Subjects:
Analysis
Dopamine
Erectile dysfunction
Gender
Literature reviews
Patients
Physiological aspects
Plasma
Psychological aspects
Psychopathology
Psychosis
Psychotropic drugs
Review
Schizophrenia
Studies
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a693t-b010e830e6623686a3dd682567387bcb05ae88cbe06262a46d0dcad1073ea58f3
cites cdi_FETCH-LOGICAL-a693t-b010e830e6623686a3dd682567387bcb05ae88cbe06262a46d0dcad1073ea58f3
container_end_page 14
container_issue 2014
container_start_page 3
container_title Schizophrenia Research and Treatment
container_volume 2014
creator Rajkumar, Ravi Philip
description Secretion of the anterior pituitary hormone prolactin can be significantly increased by antipsychotic drugs, leading to a range of adverse effects in patients with schizophrenia. However, there is evidence from a variety of studies that prolactin may also be related to symptom profile and treatment response in these patients, and recent work has identified variations in prolactin secretion even in drug-free patients. In this paper, a selective review of all relevant studies pertaining to prolactin and schizophrenia, including challenge and provocation studies, is presented. The implications of this work are discussed critically. A tentative model, which synthesizes these findings and argues for a significant role for prolactin in the development of schizophrenia, is outlined.
doi_str_mv 10.1155/2014/175360
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_36fa566cde7e4b3380705029ec055fb0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A422447625</galeid><airiti_id>P20150728004_201412_201507280031_201507280031_3_14</airiti_id><doaj_id>oai_doaj_org_article_36fa566cde7e4b3380705029ec055fb0</doaj_id><sourcerecordid>A422447625</sourcerecordid><originalsourceid>FETCH-LOGICAL-a693t-b010e830e6623686a3dd682567387bcb05ae88cbe06262a46d0dcad1073ea58f3</originalsourceid><addsrcrecordid>eNqNkt1r1EAQwIMottQ--S4BQUS5dr838UE4ih-FA0urz8tkM7nskcvGTdJy_vXu3dX7EB_MQrI7-c1vyGSS5CUlF5RKeckIFZdUS67Ik-SUkZxM4o0_3e0zeZKc9_2CxEtJqpV6npwwkcWjFqfJ3U3wDdjBtSm0ZXrTr2ztOxhq3_j5Ko3hO1u7X76rA7YOPqTTdOYGDDCMAdNbvHf4sMm8Rei6AK6H5kXyrIKmx_PH51ny4_On71dfJ7NvX66vprMJqJwPk4JQghknqBTjKlPAy1JlTCrNM13YgkjALLMFEsUUA6FKUlooKdEcQWYVP0uut97Sw8J0wS0hrIwHZzYBH-YGwuBsg4arCqRStkSNouA8I5pIwnK0RMqqINH1cevqxmKJpcV2CNAcSY_ftK42c39veJ5JlvMoePsoCP7niP1glq632DTQoh97Q6UglDLB1rVe_4Uu_Bja2CrDBNFK6lzyPTWH-AGurXysa9dSMxWMCaEVk5G6-AcVV4lLZ32LlYvxo4Q3Bwk1QjPUvW_Gwfm2Pwbfb0EbfN8HrHbNoMSsZ8-sZ89sZy_Srw77t2P_TFoE3m2B2rUlPLj_s2FEsIIDWGih5P7XgwtucPsG3kSNJJrFqmKjpMzsQ5weH7ihgv8GpxL6dg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2407657953</pqid></control><display><type>article</type><title>Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Rajkumar, Ravi Philip</creator><contributor>Kirkpatrick, Brian ; Brian Kirkpatrick</contributor><creatorcontrib>Rajkumar, Ravi Philip ; Kirkpatrick, Brian ; Brian Kirkpatrick</creatorcontrib><description>Secretion of the anterior pituitary hormone prolactin can be significantly increased by antipsychotic drugs, leading to a range of adverse effects in patients with schizophrenia. However, there is evidence from a variety of studies that prolactin may also be related to symptom profile and treatment response in these patients, and recent work has identified variations in prolactin secretion even in drug-free patients. In this paper, a selective review of all relevant studies pertaining to prolactin and schizophrenia, including challenge and provocation studies, is presented. The implications of this work are discussed critically. A tentative model, which synthesizes these findings and argues for a significant role for prolactin in the development of schizophrenia, is outlined.</description><identifier>ISSN: 2090-2085</identifier><identifier>EISSN: 2090-2093</identifier><identifier>DOI: 10.1155/2014/175360</identifier><identifier>PMID: 24800074</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Limiteds</publisher><subject>Analysis ; Dopamine ; Erectile dysfunction ; Gender ; Literature reviews ; Patients ; Physiological aspects ; Plasma ; Psychological aspects ; Psychopathology ; Psychosis ; Psychotropic drugs ; Review ; Schizophrenia ; Studies ; Womens health</subject><ispartof>Schizophrenia Research and Treatment, 2014-01, Vol.2014 (2014), p.3-14</ispartof><rights>Copyright © 2014 Ravi Philip Rajkumar.</rights><rights>COPYRIGHT 2014 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2014 Ravi Philip Rajkumar. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2014 Ravi Philip Rajkumar. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a693t-b010e830e6623686a3dd682567387bcb05ae88cbe06262a46d0dcad1073ea58f3</citedby><cites>FETCH-LOGICAL-a693t-b010e830e6623686a3dd682567387bcb05ae88cbe06262a46d0dcad1073ea58f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2407657953/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2407657953?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24800074$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kirkpatrick, Brian</contributor><contributor>Brian Kirkpatrick</contributor><creatorcontrib>Rajkumar, Ravi Philip</creatorcontrib><title>Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal</title><title>Schizophrenia Research and Treatment</title><addtitle>Schizophr Res Treatment</addtitle><description>Secretion of the anterior pituitary hormone prolactin can be significantly increased by antipsychotic drugs, leading to a range of adverse effects in patients with schizophrenia. However, there is evidence from a variety of studies that prolactin may also be related to symptom profile and treatment response in these patients, and recent work has identified variations in prolactin secretion even in drug-free patients. In this paper, a selective review of all relevant studies pertaining to prolactin and schizophrenia, including challenge and provocation studies, is presented. The implications of this work are discussed critically. A tentative model, which synthesizes these findings and argues for a significant role for prolactin in the development of schizophrenia, is outlined.</description><subject>Analysis</subject><subject>Dopamine</subject><subject>Erectile dysfunction</subject><subject>Gender</subject><subject>Literature reviews</subject><subject>Patients</subject><subject>Physiological aspects</subject><subject>Plasma</subject><subject>Psychological aspects</subject><subject>Psychopathology</subject><subject>Psychosis</subject><subject>Psychotropic drugs</subject><subject>Review</subject><subject>Schizophrenia</subject><subject>Studies</subject><subject>Womens health</subject><issn>2090-2085</issn><issn>2090-2093</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkt1r1EAQwIMottQ--S4BQUS5dr838UE4ih-FA0urz8tkM7nskcvGTdJy_vXu3dX7EB_MQrI7-c1vyGSS5CUlF5RKeckIFZdUS67Ik-SUkZxM4o0_3e0zeZKc9_2CxEtJqpV6npwwkcWjFqfJ3U3wDdjBtSm0ZXrTr2ztOxhq3_j5Ko3hO1u7X76rA7YOPqTTdOYGDDCMAdNbvHf4sMm8Rei6AK6H5kXyrIKmx_PH51ny4_On71dfJ7NvX66vprMJqJwPk4JQghknqBTjKlPAy1JlTCrNM13YgkjALLMFEsUUA6FKUlooKdEcQWYVP0uut97Sw8J0wS0hrIwHZzYBH-YGwuBsg4arCqRStkSNouA8I5pIwnK0RMqqINH1cevqxmKJpcV2CNAcSY_ftK42c39veJ5JlvMoePsoCP7niP1glq632DTQoh97Q6UglDLB1rVe_4Uu_Bja2CrDBNFK6lzyPTWH-AGurXysa9dSMxWMCaEVk5G6-AcVV4lLZ32LlYvxo4Q3Bwk1QjPUvW_Gwfm2Pwbfb0EbfN8HrHbNoMSsZ8-sZ89sZy_Srw77t2P_TFoE3m2B2rUlPLj_s2FEsIIDWGih5P7XgwtucPsG3kSNJJrFqmKjpMzsQ5weH7ihgv8GpxL6dg</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Rajkumar, Ravi Philip</creator><general>Hindawi Limiteds</general><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>188</scope><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140101</creationdate><title>Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal</title><author>Rajkumar, Ravi Philip</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a693t-b010e830e6623686a3dd682567387bcb05ae88cbe06262a46d0dcad1073ea58f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Analysis</topic><topic>Dopamine</topic><topic>Erectile dysfunction</topic><topic>Gender</topic><topic>Literature reviews</topic><topic>Patients</topic><topic>Physiological aspects</topic><topic>Plasma</topic><topic>Psychological aspects</topic><topic>Psychopathology</topic><topic>Psychosis</topic><topic>Psychotropic drugs</topic><topic>Review</topic><topic>Schizophrenia</topic><topic>Studies</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rajkumar, Ravi Philip</creatorcontrib><collection>Airiti Library</collection><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (DOAJ)</collection><jtitle>Schizophrenia Research and Treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rajkumar, Ravi Philip</au><au>Kirkpatrick, Brian</au><au>Brian Kirkpatrick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal</atitle><jtitle>Schizophrenia Research and Treatment</jtitle><addtitle>Schizophr Res Treatment</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>2014</volume><issue>2014</issue><spage>3</spage><epage>14</epage><pages>3-14</pages><issn>2090-2085</issn><eissn>2090-2093</eissn><abstract>Secretion of the anterior pituitary hormone prolactin can be significantly increased by antipsychotic drugs, leading to a range of adverse effects in patients with schizophrenia. However, there is evidence from a variety of studies that prolactin may also be related to symptom profile and treatment response in these patients, and recent work has identified variations in prolactin secretion even in drug-free patients. In this paper, a selective review of all relevant studies pertaining to prolactin and schizophrenia, including challenge and provocation studies, is presented. The implications of this work are discussed critically. A tentative model, which synthesizes these findings and argues for a significant role for prolactin in the development of schizophrenia, is outlined.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Limiteds</pub><pmid>24800074</pmid><doi>10.1155/2014/175360</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2090-2085
ispartof Schizophrenia Research and Treatment, 2014-01, Vol.2014 (2014), p.3-14
issn 2090-2085
2090-2093
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_36fa566cde7e4b3380705029ec055fb0
source Publicly Available Content Database; Wiley Open Access; PubMed Central
subjects Analysis
Dopamine
Erectile dysfunction
Gender
Literature reviews
Patients
Physiological aspects
Plasma
Psychological aspects
Psychopathology
Psychosis
Psychotropic drugs
Review
Schizophrenia
Studies
Womens health
title Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T00%3A06%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolactin%20and%20Psychopathology%20in%20Schizophrenia:%20A%20Literature%20Review%20and%20Reappraisal&rft.jtitle=Schizophrenia%20Research%20and%20Treatment&rft.au=Rajkumar,%20Ravi%20Philip&rft.date=2014-01-01&rft.volume=2014&rft.issue=2014&rft.spage=3&rft.epage=14&rft.pages=3-14&rft.issn=2090-2085&rft.eissn=2090-2093&rft_id=info:doi/10.1155/2014/175360&rft_dat=%3Cgale_doaj_%3EA422447625%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a693t-b010e830e6623686a3dd682567387bcb05ae88cbe06262a46d0dcad1073ea58f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2407657953&rft_id=info:pmid/24800074&rft_galeid=A422447625&rft_airiti_id=P20150728004_201412_201507280031_201507280031_3_14&rfr_iscdi=true